Abstract:Objective: To summarize the clinical manifestation and genetic characteristics of Chinese patients with achondroplasia (ACH) which is caused by pathogenic variants fibroblast growth factor receptor 3 (FGFR3) gene and establish the reference value of height centiles and height for age growth curve of patients for a more practical, simple and useful growth evaluation tool in China. Methods: Through a nationwide cross-sectional survey in China from July 2019 to January 2020 designed by Department of Pediatric Endocrinology and Genetics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 210 subjects (110 boys, 100 girls), who harbored the pathogenic variant of FGFR3 gene and were diagnosed with achondroplasia, were recruited. The clinical and genetic data of enrolled subjects were collected and analyzed to explore the clinical genetic characteristics of Chinese ACH patients. Furthermore, according to the data of height (body length under 2 years old) of boy and girl subjects aged 0-12 years, centiles and height for age growth curve of achondroplasia were calculated and established by LMS method respectively. Results: The characteristic clinical manifestations of 210 Chinese patients (0-14 years old) were disproportionate short stature (206/210, 98.1%), macrocephaly and characteristic facial features (205/210, 97.6%), trident configuration of the hands (191/210, 90.9%), limbs deformity (156/210, 74.3%), together with normal intelligence. Up to 81.9% (172/210) of patients have different complications, and the kyphosis (121/210, 57.6%) and narrow thoracic (79/210, 37.6%) are common complications. Besides, up to 98.6% (207/210) of patients harbored hotspot variants of FGFR3 gene which cause G380R amino acid substitutions. It is notable that the growth pattern of boy and girl patients (0-12 years old) is obviously different from the normal children (t=9.849, 9.596, P<0.01) respectively. The height different between ACH patients and normal children gradually widened with age. The average height of the boy (49.2 cm) and girl patients(48.4 cm) of achondroplasia at birth was -1.22 s and -2 s, however, at the age of twelve, the average height of the boy(113.7 cm) and girl patients(112.4 cm) of achondroplasia was -5.23 s and -6.15 s compared to currently standard reference height for age growth curve of normal children in China, respectively. Conclusions: The results of our study demonstrated that in China disproportionate short stature, macrocephaly and characteristic facial features were typical manifestations of ACH patients, and that up to 98.6% of patients harbored hotspot variants of FGFR3 gene. In addition, the reference value of height centiles and height for age growth curve of ACH patients we establish will be a valuable tool for evaluating the growth pattern, monitoring factors affecting growth, estimating ultimate height, and assessing the curative effect of growth-promoting treatments in Chinese patients with achondroplasia.

Chinese Achondroplasia is Also Defined by Recurrent G380R Mutations of the Fibroblast Growth Factor Receptor-3 Gene

Ser217cys Mutation in the Ig Ii Domain of Fgfr3 in A Chinese Family with Autosomal Dominant Achondroplasia

[Detection of Fibroblast Growth Factor Receptor 3 Gene Mutation at Nucleotide 1138 Site in Congenita Achondroplasia Patients].

Gly369Cys Mutation in Mouse FGFR3 Causes Achondroplasia by Affecting Both Chondrogenesis and Osteogenesis.

Genetical diagnosis in a congenital achondroplasia family

FGD1 Variant Associated with Aarskog–Scott Syndrome

Identification of a novel mutation in the FGFR3 gene in a Chinese family with Hypochondroplasia.

[Gly374arg Mutation in Fgfr3 Causes Achondroplasia in Mice].

Defective Lysosomal Targeting of Activated Fibroblast Growth Factor Receptor 3 in Achondroplasia.

Review of published 467 achondroplasia patients: clinical and mutational spectrum

[Exploring the Clinical Genetic Characteristics and Height for Age Growth Curve of 210 Patients with Achondroplasia in China].

A Lys644Glu Substitution in Fibroblast Growth Factor Receptor 3 (FGFR3) Causes Dwarfism in Mice by Activation of STATs and Ink4 Cell Cycle Inhibitors.

Heterozygous FGFR3 c.138G>A Mutation Presenting With Achondroplasia and Hemifacial Microsomia

Advances in the mechanism and therapies of achondroplasia

Three Novel Mutations of the FBN1 Gene in Chinese Children with Acromelic Dysplasia

Identification of a novel splicing mutation in the growth hormone (GH)-releasing hormone receptor gene in a Chinese family with pituitary dwarfism.

Two Novel Mutations of COL1A1 in Fetal Genetic Skeletal Dysplasia of Chinese

A Ser(365)-->Cys Mutation of Fibroblast Growth Factor Receptor 3 in Mouse Downregulates Ihh/PTHrP Signals and Causes Severe Achondroplasia.

Identification of Novel and Recurrent Mutations in the Calcium Binding Type Iii Repeats of Cartilage Oligomeric Matrix Protein in Patients with Pseudoachondroplasia

C278F Mutation in FGFR2 Gene Causes Two Different Types of Syndromic Craniosynostosis in Two Chinese Patients

[Fibrinogen Beta Chain Gene Mutation Contributes to One Congenital Afibrinogenemia].